At the 2026 @American_Heart (AHA) Scientific Sessions, we presented detailed clinical data for ARO-DIMER-PA, the first investigational dual-functional sIRNA treatment for mixed hyperlipidemia.
#FCSAwarenessDay highlights the importance of advancing understanding of Familial Chylomicronemia Syndrome (FCS), a rare genetic disorder that can result in recurrent acute pancreatitis. Progress takes all of us: patients, advocates & experts.
Our new SHASTA-3 and SHASTA-4 data was published by @NEJM, showing percentage change in fasting serum triglyceride levels from baseline and acute pancreatitis risk reduction in adults with severe hypertriglyceridemia (sHTG).